US-based device maker Silgan Dispensing has announced the launch of its new Gemini BE nasal pump. According to Silgan, the new pump is specifically designed to meet bioequivalence needs and “is adaptable to effectively match specific formulations for a perfect performance fit and quick time-to-market.” The company says that the pump’s spray characteristics can be adjusted for compatibility with more than 40 spray configurations to match a wide range of reference listed devices.
Silgan Dispensing VP Sales and Marketing Allan Houston commented, “Bioequivalence testing helps our customers overcome regulatory and technical barriers that have previously slowed product commercialization. The Gemini BE Nasal Pump showcases our BE Program and Silgan Dispensing’s ability to deliver expedited nasal devices that fit our customers’ needs as a replacement or secondary supply chain option.”
Read the Silgan Dispensing press release.
